Medicamen Biotech Limited (MEDICAMEQ.NS)
INR 557.3
(0.3%)
INR 557.3
(0.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.79 Billion | 1.4 Billion | 1.15 Billion | 1.12 Billion | 1.25 Billion | 1.22 Billion |
| Cost of Revenue | 1.29 Billion | 720.93 Million | 674.57 Million | 791.99 Million | 904.69 Million | 911.88 Million |
| Gross Profit | 495.49 Million | 687.74 Million | 479.87 Million | 335.16 Million | 350.34 Million | 314.15 Million |
| Operating Expenses | 335.16 Million | 512.68 Million | 289.88 Million | 160.41 Million | 177.59 Million | 159.68 Million |
| Selling, General and Administrative Expenses | 335.16 Million | 218.23 Million | 77.2 Million | 41.53 Million | 52.57 Million | 47.25 Million |
| Research and Development Expenses | - | 14.1 Million | 10.51 Million | 6.85 Million | 7.72 Million | 2.99 Million |
| Other Expenses | - | 24.62 Million | 1.27 Million | 1.21 Million | -810 Thousand | 724.65 Thousand |
| Cost and Expenses | 1.27 Billion | 1.23 Billion | 964.46 Million | 952.41 Million | 1.08 Billion | 1.07 Billion |
| Operating Income | - | 176.32 Million | 178.95 Million | 168.25 Million | 168.2 Million | 154.47 Million |
| Interest Expense | 43.97 Million | 29.22 Million | 14 Million | 10.64 Million | 5.68 Million | 9.37 Million |
| Income Tax Expense | 35.81 Million | 23.16 Million | 31.97 Million | 42.64 Million | 46.88 Million | 54.96 Million |
| Earnings before Tax | 130.75 Million | 170.45 Million | 180.94 Million | 163.94 Million | 179.8 Million | 175.22 Million |
| Net Income | 109.31 Million | 148.44 Million | 148.97 Million | 121.29 Million | 132.91 Million | 120.25 Million |
| Earnings Per Share Basic | 7.50 | 11.92 | 12.19 | 9.93 | 10.88 | 10.28 |
| Earnings Per Share Diluted | 7.50 | 11.92 | 12.19 | 9.93 | 10.88 | 10.28 |
| Weighted Average Shares Outstanding | 14.57 Million | 12.45 Million | 12.21 Million | 12.21 Million | 12.21 Million | 11.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.57 Million | 12.45 Million | 12.21 Million | 12.21 Million | 12.21 Million | 11.69 Million |
| Gross Margin | 0.28 | 0.49 | 0.42 | 0.30 | 0.28 | 0.26 |
| EBIT Margin | 0.14 | 0.19 | 0.22 | 0.18 | 0.17 | 0.17 |
| Profit Margin | 0.06 | 0.11 | 0.13 | 0.11 | 0.11 | 0.10 |
| EBITDA | 245.66 Million | 277.11 Million | 258.06 Million | 204.25 Million | 214.11 Million | 211.19 Million |
| Earnings Before Tax Margin | - | 0.13 | 0.16 | 0.15 | 0.13 | 0.13 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 430.48 Million | 473.19 Million | 1.79 Billion | 465.02 Million | 435.41 Million | 419.43 Million |
| Cost of Revenue | 336.97 Million | 337.62 Million | 1.29 Billion | 249.82 Million | 231.51 Million | 208.67 Million |
| Gross Profit | 93.51 Million | 135.56 Million | 495.49 Million | 215.19 Million | 203.89 Million | 210.76 Million |
| Operating Expenses | 76.75 Million | 95.8 Million | 344.02 Million | 184.31 Million | 175.67 Million | 158.15 Million |
| Selling, General and Administrative Expenses | 76.75 Million | 95.8 Million | - | 86.15 Million | 86.46 Million | 65.63 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5.86 Million | 5.66 Million | 23.25 Million | 8.3 Million | 5.49 Million | 3.79 Million |
| Cost and Expenses | 413.72 Million | 433.43 Million | 1.64 Billion | 434.13 Million | 407.19 Million | 366.82 Million |
| Operating Income | 16.75 Million | 39.76 Million | 151.47 Million | 39.18 Million | 33.71 Million | 52.6 Million |
| Interest Expense | 7.05 Million | 18.86 Million | 43.97 Million | 6.46 Million | 9.07 Million | 9.56 Million |
| Income Tax Expense | 7.57 Million | 6.15 Million | 35.81 Million | 12.42 Million | 9.87 Million | 7.36 Million |
| Earnings before Tax | 15.56 Million | 26.55 Million | 130.75 Million | 32.72 Million | 24.64 Million | 46.83 Million |
| Net Income | 13.51 Million | 21.27 Million | 109.31 Million | 20.29 Million | 14.76 Million | 41.77 Million |
| Earnings Per Share Basic | 1.06 | 1.68 | - | 1.60 | 1.20 | 3.30 |
| Earnings Per Share Diluted | 1.06 | 1.68 | - | 1.60 | 1.20 | 3.30 |
| Weighted Average Shares Outstanding | 12.71 Million | 12.65 Million | 12.65 Million | 12.65 Million | 12.65 Million | 12.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.71 Million | 12.65 Million | 12.65 Million | 12.65 Million | 12.65 Million | 12.65 Million |
| Gross Margin | 0.22 | 0.29 | 0.28 | 0.46 | 0.47 | 0.50 |
| EBIT Margin | 0.08 | 0.12 | - | 0.12 | 0.12 | 0.17 |
| Profit Margin | 0.03 | 0.04 | 0.06 | 0.04 | 0.03 | 0.10 |
| EBITDA | 34.46 Million | 57.5 Million | - | 57.23 Million | 51.94 Million | 73.3 Million |
| Earnings Before Tax Margin | 0.04 | 0.08 | 0.08 | 0.08 | 0.08 | 0.13 |
OGN
OVCHY
ALAGP
FEVR
SURFI
JAL